InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Robb Gary Charles, Directeur Commercial. Insider active across 2 companies, notably Corcept Therapeutics INC. Aggregated, 61 filings have been recorded. Breakdown: 0 buy · 13 sells. Total volume traded: €4.9m. Activity tracked since 30 August 2021. The latest transaction was disclosed on 17 August 2026 (Don). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Robb Gary Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations61 total
125 shares0Common StockSEC:0001193125-26-355560:0
10,000 shares@ US$116.25720.0092% mcap50.0% of flowCommon StockSEC:0001193125-26-355560:1
3,000 shares0Common StockSEC:0001193125-26-352428:1
11,530 shares0Common StockSEC:0001193125-26-352428:0
3,000 shares0Common StockSEC:0001193125-26-352428:2
600 shares0Common StockSEC:0001193125-26-298871:0
776 shares@ US$70.440.0004% mcap0.9% of flowCommon StockSEC:0001193125-26-256002:0
358 shares@ US$70.440.0002% mcap0.4% of flowCommon StockSEC:0001193125-26-256002:2
776 shares0Common StockSEC:0001193125-26-256002:1
1,000 shares0Common StockSEC:0001193125-26-227411:1
1,000 shares0Common StockSEC:0001193125-26-227411:2
5,300 shares0Common StockSEC:0001193125-26-227411:0
499 shares@ US$35.970.3% of flowCommon StockSEC:0001193125-26-092158:0
145,000 shares@ US$3.888.2% of flowCommon StockSEC:0001193125-25-335575:0
224 shares@ US$79.780.3% of flowCommon StockSEC:0001193125-25-307213:0
251 shares@ US$71.380.3% of flowCommon StockSEC:0001193125-25-196309:0
5,000 shares@ US$3.880.3% of flowCommon StockSEC:0001193125-25-188869:0
3,185 shares@ US$70.773.7% of flowCommon StockSEC:0000950170-25-088005:0
997 shares@ US$71.681.2% of flowCommon StockSEC:0000950170-25-081932:0
2,279 shares@ US$75.853.0% of flowCommon StockSEC:0000950170-25-076417:0
313 shares0Common StockSEC:0000950170-25-057620:0
233 shares0Common StockSEC:0000950170-25-044069:0
4,625 shares0Common StockSEC:0000950170-25-039604:0
250 shares@ US$60.580.3% of flowCommon StockSEC:0000950170-25-032708:0
11,000 shares@ US$3.290.7% of flowCommon StockSEC:0000950170-25-002439:0
25 of 61 declarations
About Robb Gary Charles
Robb Gary Charles is Directeur Commercial at CORCEPT THERAPEUTICS INC, where he is also listed as Chief Business Officer. He has 56 filings in total, and among the recent sampled filings, the period runs from 2021-09-01 to 2026-07-08, with EUR 0 in buys and EUR 3,883,482 in sales; the most frequent transaction nature is Don.
